NSC |
Compound |
Enrichment |
Correlation |
NSC 683661 |
Acetic acid, amino-, 9-[[(amino)carbonyl]oxy]-13-(2-amino- 1-oxoethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl- 3,20,22-trioxo-19-[(2-propenyl)amino]-2-azabicyclo [16.3.1]docosa-1(21),4,6,10,18-pentae |
0.0100995289754788 |
0.33861944 |
NSC 684902 |
Null |
0.0100995289754788 |
0.32851126 |
NSC 685005 |
Null |
0.0100995289754788 |
0.35375135 |
NSC 700913 |
Null |
0.0100995289754788 |
0.41577846 |
NSC 716034 |
Null |
0.0100995289754788 |
0.1627077 |
NSC 724058 |
3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0100995289754788 |
0.25865672 |
NSC 74702 |
Benzamide, N-[4-(2-anthraquinonylamino)-1-anthraquinonyl]- (8CI) |
0.0102077332082016 |
0.63599031 |
NSC 123461 |
Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) |
0.0102077332082017 |
0.37962612 |
NSC 1433 |
4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE |
0.0102077332082017 |
0.76284208 |
NSC 180973 |
Tamoxifen citrate |
0.0102077332082017 |
0.48699409 |